Results 231 to 240 of about 609,557 (305)

Corrigendum to "Adverse health outcomes among migrant workers and transnational families in the Asia-Pacific: a systematic review and meta-analysis" [The Lancet Regional Health-Western Pacific 2025;64: 101720]. [PDF]

Lancet Reg Health West Pac
Lin RC, Lau K, Mackey K, Matthews NR, Selvamani M, Morais B, Bouaddi O, Kim C, Iwamoto A, Fujita M, Trummer U, Dang TN, Kamenshchikova A, Zimmerman C, Hargreaves S.   +14 more
europepmc   +1 more source

Optimizing Measurement of Communication in Autistic Children and Their Caregivers: Dependability of the Caregiver‐Child Interaction

Autism Research, EarlyView.
ABSTRACT Despite widespread use of caregiver‐child interactions (CCX) to evaluate outcomes in autism interventions, little research has examined the dependability of this measure. This study applied generalizability theory to determine optimal conditions for dependable assessment of child communication and caregiver implementation of communication ...
Lauren H. Hampton, Anna‐Mari Fall, Jerrica Butler, Greg Roberts, Younghwa Noh   +4 more
wiley   +1 more source

Adolopment of clinical practice guidelines and creation of referral pathways for dermatological conditions in Pakistan. [PDF]

Lancet Reg Health Southeast Asia
Pervez A, Nizam J, Baig MI, Ahmer A, Ghulam U, Martins RS, Khawaja A, Rizvi NA, Rehman AA, Mustafa MA, Ayub B, Aamdani SS, Raza S, Rukhsar S, Tabassum S, Amber T, Shariq SF, Nadeem S, Naveed S, Haider AH, Masood S.   +20 more
europepmc   +1 more source

Behavioral Phenotype Associations With Resting State EEG Signal Complexity and Power Spectral Density in Fragile X Syndrome

Autism Research, EarlyView.
ABSTRACT Fragile X Syndrome (FXS), an X‐linked genetic condition, is associated with a wide range of phenotypic manifestations, namely intellectual disability (ID), autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and atypical behaviors.
Mélodie Proteau‐Lemieux, Inga S. Knoth, Saeideh Davoudi, Rae Buckser, Charles‐Olivier Martin, Anne‐Marie Bélanger, Valérie K. Fontaine, Hazel Maridith Barlahan Biag, Leonard Abbeduto, Sébastien Jacquemont, David Hessl, Randi J. Hagerman, Andrea Schneider, François V. Bolduc, Sarah Lippé   +14 more
wiley   +1 more source

Phylogeographic diversity of <i>Orientia tsutsugamushi</i> strains from clinical isolates in South Korea. [PDF]

Epidemiol Infect
Kang H, Choi YJ, Oh C, Kim DM, Kim YS, Lee K, Jang WJ.   +6 more
europepmc   +1 more source

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon, Sophie Delhomme, Delphine Launay, Séverine Blesson, Stéphanie Braillard, Pegah Maghdooni, Frauke Assmus, Richard Hoglund, Joel Tarning, Sabrina Loyau, Byron Arana, Mathilde Latreille‐Barbier, Yves Donazzolo   +12 more
wiley   +1 more source

Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in Breast Implants: A Case Report. [PDF]

Cureus
Quiroz Diaz H, Garcia Hernandez A, Castrejon Castro I.   +2 more
europepmc   +1 more source

Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib

British Journal of Clinical Pharmacology, EarlyView.
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang, Yunlan Fang, Phillip Wang, Xiang Liu, Jay Getsy, Kevin Rockich   +5 more
wiley   +1 more source

Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]

Open Heart
Ren Z, Shi Y, Zou J, Hao C, Li Y, Sun L, Wang D, Liu H, Liang S, Zhu B, Li C.   +10 more
europepmc   +1 more source

Asia Minor and Thrace [PDF]

, 2013
openaire   +1 more source